Tumor metastasis accounts for the majority of cancer-related deaths; it is therefore important to develop preclinical models that faithfully recapitulate disease progression. Here, we generated paired organoids derived from primary tumors and matched liver metastases in the same colorectal cancer (CRC) patients. Despite the fact that paired organoids exhibit comparable gene expression and cell morphology, organoids from metastatic lesions demonstrate more aggressive phenotypes, tumorigenesis, and metastatic capacity than those from primary lesions. Transcriptional analyses of the paired organoids reveal signature genes and pathways altered during the progression of CRC, including SOX2. Further study shows that inducible knockdown of SOX2 attenuated invasion, proliferation, and liver metastasis outgrowth. Taken together, we use patient-derived paired primary and metastatic cancer organoids to model CRC metastasis and illustrate that SOX2 is associated with CRC progression and may serve as a potential prognostic biomarker and therapeutic target of CRC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650218 | PMC |
| http://dx.doi.org/10.1186/s13045-020-00957-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Modeling Clinical Radioiodine Uptake By Using Organoids Derived From Differentiated Thyroid Cancer.
Endocrinology
November 2024
Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610000, China.
Article Synopsis
- The study focuses on radioiodine-refractory differentiated thyroid cancer (RAI-R DTC), which is a major cause of thyroid-related deaths and has limited models for predicting iodine uptake.
- Researchers created a primary tumor-derived organoid model from 20 DTC patients to assess and predict radioiodine uptake, comparing the organoids' properties to the original tumor tissue.
- The results showed that RAI-avid organoids had significantly higher iodine uptake than RAI-R organoids, with a predictive accuracy of 95% for determining iodine-refractory cases, and highlighted the potential of using tyrosine kinase inhibitors to resensitize iodine uptake in certain patients.
Spatial Transcriptome and Single Nucleus Transcriptome Sequencing Reveals Tetrahydroxy Stilbene Glucoside Promotes Ovarian Organoids Development Through the Vegfa-Ephb2 Pair.
Adv Sci (Weinh)
December 2024
School of Basic Medical Sciences, Key Laboratory of Fertility Preservation and Maintenance of Ministry of Education, Ningxia Medical University, Yinchuan, 750004, China.
Article Synopsis
- * Tetrahydroxy stilbene glucoside (TSG) is identified as a compound that encourages the growth of ovarian organoids derived from female germline stem cells.
- * The study utilizes advanced sequencing techniques to create a detailed map of ovarian organoid development and reveals that TSG promotes this process through specific interactions between granulosa cells and oocytes.
Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target.
Genome Med
November 2024
Department of Neurosurgery/Neuro-Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Background: Lung cancer brain metastases (LC-BrMs) are frequently associated with dismal mortality rates in patients with lung cancer; however, standard of care therapies for LC-BrMs are still limited in their efficacy. A deep understanding of molecular mechanisms and tumor microenvironment of LC-BrMs will provide us with new insights into developing novel therapeutics for treating patients with LC-BrMs.
Methods: Here, we performed integrated analyses of genomic, transcriptomic, proteomic, metabolomic, and single-cell RNA sequencing data which were derived from a total number of 154 patients with paired and unpaired primary lung cancer and LC-BrM, spanning four published and two newly generated patient cohorts on both bulk and single cell levels.
Establishment and drug resistance characterization of paired organoids using human primary colorectal cancer and matched tumor deposit specimens.
Hum Cell
November 2024
Molecular Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, China.
Tumor deposits (TDs) represent a specific form tumor metastasis observed in colorectal cancer (CRC). The lack of successfully established cell lines for TDs, as well as the molecular mechanisms by which TDs occur remain largely unknown. Here, we established paired CRC organoids, including a human primary cancer organoid and its TD organoid, from a 46-year-old male patient with CRC.
View Article and Find Full Text PDFMethionine restriction promotes cisplatin sensitivity of gastric cancer resistant cells by down-regulating circ-CDK13 level.
Exp Cell Res
November 2024
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi Province, China.
Background: Methionine restriction (MR) is a research direction in the treatment of gastric cancer (GC). The aim of this study was to investigate the molecular mechanism of MR on enhancing cisplatin (DDP) sensitivity of drug-resistant GC cells.
Methods: Twenty pairs of GC tissues and adjacent normal gastric mucosa tissues were collected.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!